|
May 7, 2007
BioSignia Announces Agreement To Deliver Chronic Disease
Prediction Technology Through Regional Pharmacy Chain Kerr Drug
Research Triangle Park NC – BioSignia, a leading
healthcare technology company focused on the early detection,
prevention and management of chronic diseases, today announced the
signing of a licensing agreement with regional pharmacy chain Kerr
Drug.
Under terms of the agreement, BioSignia’s revolutionary Know Your
Number® testing tool will be available to customers at participating
Kerr Health Care Centers in North Carolina. Know Your Number is
currently not available through any other pharmacy chain nationwide.
Know Your Number predicts the onset of preventable diseases,
compares your current health status against your peers, reveals what
chronic disease risks are modifiable and lets you know what factors
(e.g. lack of exercise, smoking) are contributing to the risks of
developing specific chronic conditions. Findings are communicated in
easy-to-interpret, visually compelling reports that also help
individuals track their progress.
Kerr Drug is deeply committed to providing the highest quality
health and wellness services to patients, the medical community and
healthcare sponsors. Adding Know Your Number to the roster of
solutions already offered at its health care centers serves to
further the company’s mission of being the premier community
pharmacy in North Carolina.
“Know Your Number is, by no means, a standard health risk assessment
tool,” commented Joe Heidrick, R.Ph., PharmD and program coordinator
at Kerr Drug. “It evaluates and reports a person’s chances of
developing a chronic disease in a much more accurate, actionable
manner.”
Driven by a powerful, patented predictive technology, Know Your
Number is the first and only clinically based multi-dimensional tool
to predict an individual’s risk of onset, progression, or life
expectancy related to multiple chronic diseases.
“We are extremely excited at the opportunity to work with one of the
most recognized and respected retail organizations in the nation,”
commented Tim Smith, CEO of BioSignia. “We firmly believe in the
power of the Know Your Number solution and the benefits it will
deliver to Kerr Drugs’ customers.”
***
About BioSignia
Headquartered in Cary, N.C., BioSignia is a leading technology
and software company focused
on bringing innovative risk assessment modeling solutions to the preventive healthcare
and life insurance underwriting markets. BioSignia's patented
Technology, Synthesis Analysis, provides the underpinnings of the
healthcare application, Know Your Number® (KYN), and life insurance application, Mortality Assessment Technology® (MAT).
This modeling capability represents a quantum leap forward in both morbidity and mortality risk assessment. BioSignia's R&D
team has continued to advance synthesis modeling, continuously updating it to reflect the ever expanding need for better risk
assessment, as well as effective chronic disease prevention, management, and treatment. For more information about BioSignia, visit:
www.biosignia.com.
About Kerr Drug
Kerr Drug is one of the most recognized and respected names in the
chain drug industry. With its roots in the Carolinas and
headquarters in Raleigh, North Carolina, Kerr Drug is taking the
vision of community pharmacy farther than any other drug chain. The
company has placed its future on its unique ability to provide
patients, the medical community, and health plan sponsors, access to
the most comprehensive and convenient health and wellness offering
in the industry. With a mission to be the most comprehensive
provider of pharmacy and related health care services, while
continuing to be the most reliable provider of health related and
convenience items, Kerr is currently providing services that far
exceed the traditional drug store mix. For more information, please
visit
www.kerrdrug.com.
|
